<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Validity of the cancer stem cell concept under discussion</title>
	<atom:link href="http://hematopoiesis.info/2008/12/28/validity-of-the-cancer-stem-cell-concept-under-discussion/feed/" rel="self" type="application/rss+xml" />
	<link>http://hematopoiesis.info/2008/12/28/validity-of-the-cancer-stem-cell-concept-under-discussion/</link>
	<description>Blood Stem Cell &#38; Cell Therapy Trends</description>
	<lastBuildDate>Fri, 20 Jan 2012 01:41:14 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
	<item>
		<title>By: Dr. R. Rajaraman</title>
		<link>http://hematopoiesis.info/2008/12/28/validity-of-the-cancer-stem-cell-concept-under-discussion/#comment-12523</link>
		<dc:creator>Dr. R. Rajaraman</dc:creator>
		<pubDate>Mon, 12 Jul 2010 20:29:42 +0000</pubDate>
		<guid isPermaLink="false">http://hematopoiesis.info/2008/12/28/validity-of-the-cancer-stem-cell-concept-under-discussion/#comment-12523</guid>
		<description>There is new evidence for the concept of neosis executes Epithelial-Mesenchymal Transition. In addition, the so called Cancer Stem Cells are only short-lived and these cells soon undergo Mesenchymal-epithelial transition. This fits very well with the neosis paradigm of carcinogenesis, which states that Tumor Initiating or Repopulating Raju Cells (TIRCs or TRRCs) are produced repeatedly during the continuous growth of tumor cells. Just as in the case of embryonic development, where cells undergo several EMTs and METs, tumor cells also undergo several EMTs and METs during their growth, each time producing newer batches of Tumor Repopulating Raju cells either spontaneously or after genotixin-therapy-induced senescent phase, that results in the growth of resistant cells, via EMT followed by neosis. Thus Raju cells represent the progenitor cells, that undergo transit amplification to mature into cancer cells and do not fit to be called cancer stem cells. This signifies the importance of neosis playing a dynamic role in  tumor growth and origin of tumor cell heterogeneity. Dr. Denys Wheatley, Edior in Chief of BioMed Central, has written four editorials in support of neosis and has warned that Cancer biologists, Cell  biologists, Pathologists and Clinician scientists ignore neosis &quot;to their own peril&quot;.</description>
		<content:encoded><![CDATA[<p>There is new evidence for the concept of neosis executes Epithelial-Mesenchymal Transition. In addition, the so called Cancer Stem Cells are only short-lived and these cells soon undergo Mesenchymal-epithelial transition. This fits very well with the neosis paradigm of carcinogenesis, which states that Tumor Initiating or Repopulating Raju Cells (TIRCs or TRRCs) are produced repeatedly during the continuous growth of tumor cells. Just as in the case of embryonic development, where cells undergo several EMTs and METs, tumor cells also undergo several EMTs and METs during their growth, each time producing newer batches of Tumor Repopulating Raju cells either spontaneously or after genotixin-therapy-induced senescent phase, that results in the growth of resistant cells, via EMT followed by neosis. Thus Raju cells represent the progenitor cells, that undergo transit amplification to mature into cancer cells and do not fit to be called cancer stem cells. This signifies the importance of neosis playing a dynamic role in  tumor growth and origin of tumor cell heterogeneity. Dr. Denys Wheatley, Edior in Chief of BioMed Central, has written four editorials in support of neosis and has warned that Cancer biologists, Cell  biologists, Pathologists and Clinician scientists ignore neosis &#8220;to their own peril&#8221;.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: &#187; Complexity of cancer stem cells Hematopoiesis: Blood Stem Cell &#38; Lineages</title>
		<link>http://hematopoiesis.info/2008/12/28/validity-of-the-cancer-stem-cell-concept-under-discussion/#comment-11385</link>
		<dc:creator>&#187; Complexity of cancer stem cells Hematopoiesis: Blood Stem Cell &#38; Lineages</dc:creator>
		<pubDate>Sat, 27 Jun 2009 18:44:44 +0000</pubDate>
		<guid isPermaLink="false">http://hematopoiesis.info/2008/12/28/validity-of-the-cancer-stem-cell-concept-under-discussion/#comment-11385</guid>
		<description>[...] Reports Stem Cells)John Dick: careful assays for cancer stem cells.  (Nature Reports Stem Cells)Validity of the cancer stem cell concept under discussion (Hematopoiesis)Cancer stem cells - how mouse model can change the concept (Hematopoiesis)Cancer [...]</description>
		<content:encoded><![CDATA[<p>[...] Reports Stem Cells)John Dick: careful assays for cancer stem cells.  (Nature Reports Stem Cells)Validity of the cancer stem cell concept under discussion (Hematopoiesis)Cancer stem cells &#8211; how mouse model can change the concept (Hematopoiesis)Cancer [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Alex</title>
		<link>http://hematopoiesis.info/2008/12/28/validity-of-the-cancer-stem-cell-concept-under-discussion/#comment-10947</link>
		<dc:creator>Alex</dc:creator>
		<pubDate>Mon, 05 Jan 2009 13:43:38 +0000</pubDate>
		<guid isPermaLink="false">http://hematopoiesis.info/2008/12/28/validity-of-the-cancer-stem-cell-concept-under-discussion/#comment-10947</guid>
		<description>I got a reply to this discussion via email from Dr. R. Rajaraman. He agreed to posted it here:

-------------------
It is well known that from the beginning,this hypothesis was haunted by the possible detrimental effects on cells during isolation and sorting cells for xeno-transplantation studies. In addition the studies by Taussig et al has demonstrated that even in  hAML system, which need not use drastic enzymatic digestion to isolate single cells, the simple process of exposing the cells to antibodies will drastically affect the viability of cells in the NOD/SCID mice system. This has been born out by the studies of Quintana et al. Besides, nobody knows about the source of the putative cancer stem cells. In addition, there is not direct proof for the asymmetric division potential of the so called CSCs.
  What worries me is the act that there are much better explanations for the process of carcinogenesis. For example, my work on neosis, which nobody seems to care about has offered a perfectly logical explanation for the origin of tumor initiating Raju cells, which are produced repetitively. This will explain the variation in the number of tumor initiating cells. In addition, we have shown that when tumor cells are exposed to current non-surgical treatments, the cells enter senescent phase and undergo neosis which yields Tumor Repopulating Raju cells which are resistant, thus giving rise to the resistant tumor growth. (Ref: R. Rajaraman et al. Cancer Cell Int 2006.6:25) Complete info can be seen in the internet by googling for the words &quot;Neosis + R. Rajaraman&quot;. I would personally welcome your comments on this hypothesis, which is based on video documentation, unlike the CSC hypothesis, which is based on assumptions and circumstantial evidence, which has now turned out to be erroneous.
--------------------

please welcome to comment!</description>
		<content:encoded><![CDATA[<p>I got a reply to this discussion via email from Dr. R. Rajaraman. He agreed to posted it here:</p>
<p>&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br />
It is well known that from the beginning,this hypothesis was haunted by the possible detrimental effects on cells during isolation and sorting cells for xeno-transplantation studies. In addition the studies by Taussig et al has demonstrated that even in  hAML system, which need not use drastic enzymatic digestion to isolate single cells, the simple process of exposing the cells to antibodies will drastically affect the viability of cells in the NOD/SCID mice system. This has been born out by the studies of Quintana et al. Besides, nobody knows about the source of the putative cancer stem cells. In addition, there is not direct proof for the asymmetric division potential of the so called CSCs.<br />
  What worries me is the act that there are much better explanations for the process of carcinogenesis. For example, my work on neosis, which nobody seems to care about has offered a perfectly logical explanation for the origin of tumor initiating Raju cells, which are produced repetitively. This will explain the variation in the number of tumor initiating cells. In addition, we have shown that when tumor cells are exposed to current non-surgical treatments, the cells enter senescent phase and undergo neosis which yields Tumor Repopulating Raju cells which are resistant, thus giving rise to the resistant tumor growth. (Ref: R. Rajaraman et al. Cancer Cell Int 2006.6:25) Complete info can be seen in the internet by googling for the words &#8220;Neosis + R. Rajaraman&#8221;. I would personally welcome your comments on this hypothesis, which is based on video documentation, unlike the CSC hypothesis, which is based on assumptions and circumstantial evidence, which has now turned out to be erroneous.<br />
&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;</p>
<p>please welcome to comment!</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Blind.Scientist &#187; Blog Archive &#187; Cancer Research Blog Carnival #17</title>
		<link>http://hematopoiesis.info/2008/12/28/validity-of-the-cancer-stem-cell-concept-under-discussion/#comment-10937</link>
		<dc:creator>Blind.Scientist &#187; Blog Archive &#187; Cancer Research Blog Carnival #17</dc:creator>
		<pubDate>Fri, 02 Jan 2009 15:58:59 +0000</pubDate>
		<guid isPermaLink="false">http://hematopoiesis.info/2008/12/28/validity-of-the-cancer-stem-cell-concept-under-discussion/#comment-10937</guid>
		<description>[...] these models useful for all types of cancer or is it a more complex problem? Alexey also brings us Validity of the cancer stem cell concept under discussion posted at Hematopoiesis. Continuing on the cancer stem cell theme, this post gets different [...]</description>
		<content:encoded><![CDATA[<p>[...] these models useful for all types of cancer or is it a more complex problem? Alexey also brings us Validity of the cancer stem cell concept under discussion posted at Hematopoiesis. Continuing on the cancer stem cell theme, this post gets different [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

